
Cipla Reports 55% Decline in Q4 Net Profit to ₹554.64 Crore, Revenue Slips 3% Year-Over-Year
Cipla Reports 54.6% Decline in Net Profit for Q4FY26
Pharma major Cipla reported a net profit of ₹554.64 crore for the fourth quarter of FY26, a significant decline of 54.6% from ₹1,221.8 crore in the year-ago period. The company's financial performance has shown a notable dip, with a decrease in revenue for the quarter.
Cipla's revenue in Q4FY26 declined by 3% to ₹6,451.2 crore from ₹6,730 crore, year-on-year (YoY). This decline in revenue has contributed to the decrease in net profit for the company.
| Financial Performance | Q4FY26 | Q4FY25 | YoY Change |
|---|---|---|---|
| Net Profit | ₹554.64 crore | ₹1,221.8 crore | -54.6% |
| Revenue | ₹6,451.2 crore | ₹6,730 crore | -3% |
Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data
In addition to the decline in financial performance, the company's Board of Directors also recommended a final dividend of ₹13 per equity share for the financial year ended 31st March, 2026. The dividend, upon declaration by the shareholders, will be paid within 30 days from the date of the Annual General Meeting.
The record date for the purpose of determining the eligible shareholders for the payment of final dividend has been set as 5 June 2026. At 12:48 PM, Cipla share price was trading 2.92% higher at ₹1,329.70 apiece on the BSE.
Investor Takeaway
Cipla's Q4 net profit declined by 54.6% YoY, and revenue slipped 3% YoY, indicating a challenging quarter for the company.
More in Economy

Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

MoSPI Releases Uniform Norms for DDP Estimates with 2022-23 Base Year
